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Abstract
Background: For a quicker delivery of laboratory test results to the hospital emergency department (ED), we implemented an autoverification 
system based on the reference change value (RCV). The aim of this study was to assess how the RCV based autoverification reflected on turnaround 
time (TAT) and on physician satisfaction.
Materials and methods: The laboratory information system (LIS) was programmed to autoverify the results as long as they were within the range 
settled by RCV, so that the autoverified results were reported to the physician as soon as the tests were carried out, without any further intervention. 
We analyzed the same three-month periods’ TAT and verification time (VFT) from the years prior to and following the implementation of RCV auto-
verification. The change in physicians’ satisfaction levels was assessed using the hospital’s Annual Physician Satisfaction Survey (APSS). Over sixty 
percent of physicians completed the questionnaire, and the amount of daily ED test requests (nearly three hundred) did not vary throughout the 
duration of this study.
Results: Mann-Whitney U test showed that the VFT was significantly reduced in all the test but troponin I. There were substantial reductions in TAT 
medians (haemogram, 75%; fibrinogen, 41%; prothrombin time, 40%; sodium, 27%). The percentage of physicians satisfied with the haematologi-
cal and biochemical tests´  TAT increased from 84% to 93% and from 86% to 91% respectively.
Conclusions: Our results reveal that VFT and TAT were severely reduced in most emergency tests, greatly improving physicians’ satisfaction with 
TAT.
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Introduction
Emergency department (ED) crowding represents 
an international problem that may affect the qual-
ity and access of health care. Common causes of 
ED crowding include non urgent visits, “frequent-
flyer” patients, influenza season, inadequate staff-
ing, inpatient boarding, and hospital bed shortag-
es (1,2). The rise in the number of ED patients has a 
negative impact on waiting times, being thence 
closely related to the patients’ dissatisfaction (3), 
and most importantly, to the diminution in the 
quality of the care provided (4,5). Therefore, it is 
essential to limit the effects of any factor that 
might interfere with the output of admitted pa-
tients.
Among many other factors that contribute to the 
bottleneck effect in the ED, delays in laboratory 
have always been considered very influential. In 
fact, the increase in laboratory TAT has been re-
ported to cause delays in treatments, as well as a 
lengthening of the patients’ time of stay by more 
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than 50% (6-8). Moreover, the aforementioned rise 
in the volume of visits results in an increase of the 
number of specimens that are sent to the emer-
gency laboratories, which aggravates the situation 
and worsens the delay in turnaround times. That is 
the reason why laboratories need to provide strat-
egies to minimize these lags, thus relieving the 
pressure put on the ED and contributing to a 
quicker diagnosis and a better treatment of the 
patients. 
Turnaround time covers the entire process that 
ranges from sample registration to the reporting 
of the results, that is, the three phases of the han-
dling of any specimen sent to the laboratory: 1) 
pre-analytic phase (requesting, collection and 
transport of specimens); 2) analytic phase (analysis 
of specimens); 3) post-analytic phase (time to veri-
fy and report the test result to physicians). Labora-
tories nowadays have optimized their organiza-
tion thanks to the automation of the pre-analytic 
and analytic phases, thus managing to reduce 
their workload (9,10). The post-analytic phase, and 
particularly its most important process, verifica-
tion (the laboratory staff’s approval of results that 
match the clinical features and physiopathological 
status of patients) is a dull manual review task that 
demands a great deal of the laboratory staff’s ef-
fort and time, to the point of preventing them 
from focusing on the small number of test results 
that are actually controversial and need greater at-
tention (11). Therefore, the automation of verifica-
tion is a new, strategic opportunity to optimize the 
laboratory staff s´ efforts and tests’ turnaround 
times, allowing for the immediate release of the 
results, provided that they meet the required rules. 
Automatic verification, i.e. autoverification, is per-
formed through an expert system within the Lab-
oratory Information System (LIS), or other middle-
ware software. The test results that fulfil the estab-
lished requirements are handed out to the ED as 
soon as they emerge from the analyzers. These re-
quirements may be chosen based on population 
reference ranges, analytical measurement ranges, 
critical values, delta checks, instrument error flags, 
interference indices and any other predetermined 
set of criteria settled by the laboratory (12).
The autoverification criterion that has recently 
been implemented in our emergency laboratory is 
that the reference change value (RCV) limits must 
not be surpassed. RCV is a very objective and alto-
gether ideal strategy for the assessment and verifi-
cation of serial results, because the evaluation of 
these results is based on the unavoidable variation 
generated by the analytical imprecision and with-
in-individual biological variation (13). Although 
certain disadvantages of using biological variation 
for reference change values have been pointed 
out (14) and RCV may need some improvement, it 
is important to consider that it is currently an in-
valuable tool in laboratory medicine (15).
Any change in consecutive measurements within 
the limits defined by RCV is judged as non-signifi-
cant, and the results are autoverified. However, 
when the range is surpassed, test results are held 
for manual verification by laboratory staff, so that 
the significance of this alteration can be evaluated. 
Autoverification has been proven to be an enor-
mous advantage to the laboratory because it de-
creases verification workload, increases productiv-
ity, through important savings in Full-time equiva-
lents (FTE) to result-review functions and reduces 
overall error rates as well as TAT (11,16-18). Clini-
cians have always viewed the timeliness of the re-
porting of results as a key criterion when judging 
the performance of laboratories. They also consid-
er that a reduction in laboratory TAT is essential for 
proper patient care and treatment (8,19). This 
prompted us to investigate whether the improve-
ment noted on TAT after the introduction of RCV-
based autoverification was perceived by ED physi-
cians. Since our hospital’s quality unit conducts an 
annual physician satisfaction survey, we compared 
the resulting level of satisfaction obtained regard-
ing the emergency tests report turnaround time 
with that of the year before the implementation of 
RCV-based autoverification. 
Material and methods
The reference value that we used to determine 
significant changes in each test’s serial results was 
calculated following the term introduced by Harris 
and Yasaka, RCV (20). Three years before this study 
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was started, our laboratory implemented a quality 
management system which fulfils the require-
ments of the ISO 9001:2008. Since then, it is guar-
anteed that the standard operating procedures 
are well established and respected by our techni-
cal staff, so that the pre-analytical conditions are 
unvarying and the RCV formula becomes: 
RCV = 21/2 x Z x (CVA2 + CVI 2) 1/2
where Z indicates the number of standard devia-
tions appropriate to the desired   probability, 1.96 
for P < 0.05; CVA, analytical imprecision; and CVI, 
within subject biological variation. The CVA of each 
test was provided by imprecision testing in labora-
tory and the estimates of CVI are available for 
many biological compounds (21).
Autoverification was activated in every test file of 
our LIS (SIGLO, Horus Hardware S.A., Las Rozas de 
Madrid, Spain) after introducing the correspond-
ing RCV figure in the “delta-check” box and select-
ing a period of three years for the time back ap-
plied in the “delta-time” box. Tests whose results 
had been analyzed less than three years ago, and 
whose present result is within the limits defined 
by RCV, are autoverified. However, when the range 
defined by RCV is surpassed, test results are held 
for manual verification by laboratory staff, so that 
the significance of this alteration can be evaluated. 
Tests with no previous results, or those whose last 
result had been obtained more than three years 
ago were held for manual validation.
RCV for sodium in serum, for example, equals 3.8% 
in our laboratory (as our analytical imprecision is 
1.2% and the within subject biological variation is 
0.7%), so when the autoverification according to 
RCV is activated in the sodium file, any patient 
with a sodium test result included within the inter-
val (last sodium result within three years back ± 
0.0385 x last sodium result within three years 
back), would be autoverified for this test. Patients 
whose sodium results were out of this interval, as 
well as patients without a previous result for sodi-
um, or those with previous results from more than 
three years ago, would be held for manual verifica-
tion. 
Creatin kinase-MB, mass and troponin I were run 
on UniCel DxI 800 Immunoassay System (Beckman 
Coulter Inc, Brea, USA). Coagulation tests were 
performed on ACL TOP 500 CTS (Instrumentation 
Laboratory Werfen Co, Bedford, USA). The bio-
chemical tests were performed on UniCel DxC 800 
Synchron Clinical System (Beckman Coulter Inc, 
Brea, USA). Hemograms were run on COULTER LH 
750 Hematology Analyzer (Beckman Coulter Inc, 
Brea, USA). All analyzers and the associated re-
agents were used according to the manufacturer s´ 
instructions.
For each test, TAT was the period from when the 
specimen was received in the laboratory until the 
result was reported. VFT was the period from 
when the test was completed until the result was 
reported. TAT and VFT medians and autoverifica-
tion percentages (%VT) for each test were taken 
from the statistical module of the LIS. In this re-
gard, two equivalent three-month periods, from 
the year prior to and the one following the imple-
mentation of RCV-based autoverification, were ex-
amined. 
To measure the physicians’ satisfaction we used 
the Annual Physician Satisfaction Survey (APSS), 
carried out by the Quality of Care Unit of the hos-
pital. Every year, the APSS requests the clinicians’ 
assessment of the emergency turnaround time. To 
do so, it uses the Likert scale, which classifies the 
participants in five different categories: very dis-
satisfied, rather dissatisfied, indifferent, satisfied 
and very satisfied. Thus, we compared results from 
the years before and after implementation of the 
RCV based autoverification. The survey was 
launched using the online tool LimeSurvey version 
2.05 + Build 140520 (www.limesurvey.org) which 
feeds back the percentage of responses and the 
total numbers, but not the raw data. 
All the statistical analyses used were performed 
using SPSS Statistics v15 (IBM, Chicago, IL).
Results
During the three-month period prior to the intro-
duction of RCV-based autoverification, 252,767 
tests were carried out for 10,769 ED patients. All of 
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these tests were manually validated. After the in-
troduction of the new autoverification method, 
252,225 tests were performed for 10,930 ED pa-
tients throughout an equivalent three-month pe-
riod. This time, 140,294 tests (56%) were autoveri-
fied. The improvement was applied to 59% of the 
population, as 6437 out of 10,930 ED patients had 
at least one test autoverified. 
The TAT and VFT medians of the third trimester of 
the years before and after RCV autoverification im-
plementation, for each test, are shown in Table 1. 
When conducting the comparisons, as in no case 
the data in both groups were sampled from a nor-
mally distributed population (Kolmogorov-Smirnov 
tests), the nonparametric Mann-Whitney U tests 
were done.  Mann-Whitney U tests revealed signifi-
cant differences (P < 0.001) between the two terms 
for TAT and VFT in all the tests, with the exception of 
troponin I. Troponin I showed no significant chang-
es in VFT and its %VT was very small (25%). 
Table 1 also shows the remarkable reduction of 
TAT for most of the tests studied, displayed as per-
centage of turnaround time reduction (%TATR). For 
troponin I this reduction was only 12%. It is worth 
noting that every haematological test showed a 
much larger %TATR than any biochemical one.
Concerning physicians´  satisfaction, 89 out of 142 
physicians (61%) completed the annual survey af-
Test TATB TATA VFTB VFTA %TATR %VT
Total bilirubin 41.2  (30.2–48.2) 30.9 (22.1–42.5) 11.2 (6.2–14.0) 3.5 (0–8.4) 25 57
Creatinine 40.3 (24.2–47.4) 31.7 (18.5–42.0) 10.7 (5.1–12.2) 4.9 (0–7.5) 21 46
Glucose 40.2 (24.5–47.1) 32.4 (18.5–41.8) 10.6 (5.2- 12.1) 5.6 (0–7.4) 19 38
Total protein 41.2 (29.7–48.3) 33.2 (20.2–42.5.) 11.1 (8.0–13.5) 5.7 (2.2–8.6) 19 34
Urea 40.2 (24.2–46.3) 30.7 (17.8–37.5) 10.6 (5.3–12.1) 4.0 (0–6.5) 24 55
Troponin I 47.4 (34.3–54.6) 41.9 (32.5–53.8) 9.6 (6.3–12.2) 8.7 (6.2–12.2)* 12 25
Creatine Kinase 44.7 (32.6–50.1) 35.5 (24.5–42.2) 11.1 (6.3–13.8) 5.0 (0–6.2) 21 52
Creatin Kinase MB, mass 53.7 (35.9–57.5) 45.7 (32.2–52.8) 9.0 (6.3–12.2) 3.7 (1.5–6.5) 15 41
Hemogram 26.6 (8.2–35.5) 6.7 (4.2–15.4) 25.2 (8.4–34.3) 5.0 (0–10.1) 75 51
Prothrombin time 36.9 (26.2–38.3) 22.0 (20.1–25.1) 16.7 (6.2–19.3) 6.6 (0–7.5) 40 52
Fibrinogen 36.8 (26.2–38.3) 21.6 (20.2–25.1) 16.7 (6.2–19.4) 6.2 (0–7.8) 41 55
Activated partial 
thromboplastin time 37.2 (28.5–42.3) 27.4 (22.8–35.2) 15.4 (9.3–19.5) 9.2(2.2–13.2) 26 30
Sodium 40.5 (24.5–47.1) 29.7 (18.5–40.8) 10.9 (5.2–12.1) 2.7 (0–5.0) 27 64
Potassium 39.7 (24.4–46.9) 30.6 (18.5–40.9) 10.9 (4.9–12.0) 3.1 (0–6.8) 26 53
Chloride 40.5 (24.5–47.1) 29.9 (18.5–41.8) 11.8 (5.2–12.1) 5.6 (0–7.3) 20 60
Calcium 42.2 (29.7–48.3) 32.2 (22.1–42.5) 11.7 (6.2–14.0) 5.0 (0–8.5) 24 47
Phosphate 43.1 (29.7–48.3) 32.4 (22.1–42.5) 12.2 (6.2–14.7) 4.9 (0–8.5) 25 51
Alanine aminotransferase 41.2 (28.6–48.1) 31.0 (23.5–41.2) 11.2 (6.4–13.9) 3.6 (0–6.8) 25 54
Aspartate aminotransferase 41.2 (28.6–48.1) 32.2 (23.5–41.2) 11.2 (6.4–13.9) 4.6 (0–6.2) 22 46
α-Amylase 41.6 (30.1–49.6) 34.9 (24.7–42.6) 11.0 (6.3–13.7) 6.6 (1.9–9.2) 16 32
Cholinesterase 40.4 (30.2–49.4) 34.2 (25.5–43.2) 9.0 (5.8–13.8) 6.0 (2.7–9.6) 15 28
Data are expressed as median (interquartile range) in minutes. TATB–turnaround time before autoverification implementation; 
TATA–turnaround time after autoverification implementation; VFTB–verification time before autoverification implementation; 
VFTA–verification time after autoverification implementation; %TATR–percentage of turnaround time reduction: 100 (1- (TATA / 
TATB)); %VT–percentage of autoverified tests.  
*Mann-Whitney U test showed no significant difference vs. VFTB, P = 0.399.
Table 1. Laboratory turnaround time and verification time before and after RCV-based autoverification implementation 
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ter the introduction of RCV-based autoverification, 
and 118 physicians (70%) had filled out the ques-
tionnaire the previous year.   
Figure 1 shows physician satisfaction with TAT for 
biochemical (BTAT) and haematological (HTAT) 
tests before and after the implementation of RCV 
based autoverification. The percentage of physi-
cians who felt satisfied with the HTAT (combining 
both “satisfied” and “very satisfied” categories) 
was increased from 84 to 93%, and from 86 to 91% 
with BTAT; the percentage of dissatisfied clinicians 
(unifying the “rather dissatisfied” and “very dissat-
isfied” categories) showed no reduction with HTAT, 
from 3.5 to 3.7%. However, it showed an important 
increment (more than twice the initial value) from 
1.7 to 3.8% in BTAT. Interestingly enough, the per-
centage of physicians in the “indifferent” category 
showed an important reduction from 12 to 2.8% in 
HTAT and from 12 to 5.1% in BTAT. Thus, we ob-
served an overall improvement in satisfaction with 
a clear reduction in the percentage of the “indiffer-
ent” category (BTAT 7.6% and HTAT 9.5% reduc-
tion) and a notable increment in the percentage of 
the “satisfied” or “very satisfied” categories (BTAT 
5.5% and HTAT 9.3% increment). It is worth noting 
that the “very satisfied” category was importantly 
increased on both haematological and biochemi-
cal tests (7.1% and 8.6% respectively).
Discussion
We activated the built-in RCV based automatic 
verification software of our LIS in the emergency 
laboratory to optimize the laboratory staff s´ efforts 
and tests’ turnaround times.
Verification workload decreased importantly. A 
three-month period after the software activation, 
140,294 tests (56%) were autoverified. This event 
probably permitted a more efficient staff s´ manual 
verification. There was not any reduction in Full-
time equivalents because in our laboratory there 
is only one physician on call.
In this study, we explored above all whether auto-
verification based on RCV had a positive impact 
on laboratory turnaround time for emergency 
tests, and more importantly, if this improvement 
impacted ED physician satisfaction. 
Papers on autoverification of acute-care patient 
tests but also providing TAT data are rather scanty 
in the literature. In spite of that, we found some ar-
ticles to compare our results with. Torke et al. re-
ported that TAT for stat chemistries (sodium, po-
tassium, chloride, glucose, blood urea nitrogen 
and creatinine) was reduced by 10 minutes (48 
minutes before vs 38 minutes after autoverifica-
tion) (11). Table 1 shows for these tests similar dif-
ferences between TAT before and after autoverifi-
cation. Cardiac test TAT, creatine kinase-MB and 
troponin I, decreased 11 minutes (from 45 minutes 
to 34 minutes). Our results were similar for creatine 
kinase-MB but only decreased 5.5 minutes for tro-
ponin I. The small percentage of autoverified re-
sults for troponin I might explain this. Cheng et al. 
Figure 1. Categorised percentage of ED physician’s satisfaction 
on turnaround time before and after RCV autoverification im-
plementation. (A) Haematological tests. (B) Biochemical tests.
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showed very significant decreases in TAT both for 
the metabolic panel and for troponin I (17). The 
median after autoverification was 30.3 and 44.5 
minutes respectively, close to ours. The TAT before 
in both cases was reported very high. 
Blick study, providing services to critical care areas 
through middleware software autoverification 
and Six Sigma initiatives, describes 93% of hemo-
globin results under 30 minutes and TAT for potas-
sium of 27 ± 7.2 minutes (mean ± SD) (22). Potassi-
um TAT was similar to ours. For hemoglobin, we 
delivered results more rapidly, 75% in 15.4 minutes 
(Q3) after autoverification (93th percentile was 
23.5 minutes, data not shown in Table 1).
Onelöv et al. reported coagulation assay data from 
laboratories performing tests on a 24/7 basis (23). 
They activated the delta check function on their 
LIS software for autoverification (delta range for 
prothrombin time 40%, for the rest of assays 20%; 
delta time 90 days) and compared two similar 
weeks. The median TAT for all routine coagulation 
assays was 37.0 and 32.0 min, during the weeks be-
fore and after, respectively. The introduction of 
an autoverification protocol decreased the median 
overall TAT by 5 min. Our TATs were decreased to a 
greater extent (Table 1, %TATR from 26% for acti-
vated partial thromboplastin to 41% for fibrino-
gen).
We achieved smaller percentages of autoverified 
tests (25% - 64%) in comparison to Torke et al. (62% 
- 73%), an analogous study but where a set of mul-
tiple rules was used (11). This could be due both to 
the fact that the RCV based autoverification re-
quires the existence of previous values to compare 
the obtained results with and that it was the only 
rule that we applied in autoverification. Concern-
ing the percentages of autoverification, RCV based 
autoverification as the sole rule in our emergency 
laboratory yielded appealing results, as according 
to Cava-Valenciano report (24), while in outpatient 
laboratories up to 70% of the results are autoveri-
fied, in centers of complex pathologies the per-
centage may be only 10%.
The lack of significant differences for VFT in tro-
ponin I was probably due to the very small per-
centage of autoverified results (%VT) and was con-
sistent with the low %TATR shown for this test. Re-
garding the very small %VT for troponin I, it is im-
portant to point out that in addition to the previ-
ous value that RCV autoverification requires, the 
troponin I test used was conventional, so there 
were many results under the limit of detection (10 
ng/L). Therefore, a very large amount of results 
handed out by the analyzer to the LIS as alphanu-
meric results, i.e. < 10 ng/L, were excluded from 
the formula for autoverification. 
Despite this technical drawback concerning tro-
ponin I, we have introduced a significant innova-
tion for TAT reduction that saves time objectively 
and securely where it is most needed: the use of 
RCV as a tool for autoverification in ED population. 
This tool for autoverification is a very simple meth-
od based just on a physiological and unbiased 
rule. As it does not depend on a set of rules or al-
gorithms that might be accidentally changed or 
inactivated, and as it requires hardly any mainte-
nance, it is a very safe mean of generating impor-
tant reductions in TATs while ensuring analytical 
and post analytical quality. This tool can contrib-
ute to the great benefits that others standard soft-
wares have shown with regard to autoverification 
(25).
Moreover, our results showed that these signifi-
cant reductions in TATs were accompanied by an 
overall improvement in satisfaction of the ED phy-
sicians.  Due to the method employed in the APSS 
we did not have access to the raw data. Therefore, 
an inferential statistical test was unavailable. This is 
probably the main limitation of the survey as a 
tool for investigation, but it can also be regarded 
as a double blind experiment, since neither the 
data analyst nor the physicians were aware of the 
fact that this study was being carried out. Double-
blinding was relatively easy to achieve as, in spite 
that our emergency laboratory and the ED are 
very well connected for patient s´ sake at large, 
many times internal protocols are not diligently 
communicated to each other. The high workload 
that both departments have to put up with may 
be responsible of this. Besides, we were not really 
testing or introducing any new kind of expert sys-
tem or middleware that would rapidly spread from 
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the laboratory and reach the ED. It was just that 
the software of our LIS could be activated for RCV 
based autoverification, so after a short pre-pro-
duction phase which was entirely satisfactory, we 
launched it. Our first purpose in activating this 
kind of autoverification was to alleviate the in-
creased workload that each day the only laborato-
ry physician on call had to deal with. After noticing 
the important test TAT reductions resulting from 
the implementation of this autoverification, we 
decided to explore the impact that it had had on 
ED physician satisfaction. 
As we described in the results section, there were 
significant changes worth discussing (Figure 1); 
and considering that no other action involving the 
TAT was taken during the realization of this study, 
this improvement in satisfaction may be regarded 
as a direct effect of the implemented RCV based 
autoverification.
As many authors have considered, reduction of 
TAT can be essential to improve the user’s satisfac-
tion with the laboratory (8,18,26,27). In fact, TAT is 
an indicator used to evaluate the quality of care 
and the perceived quality of the laboratories; it is 
conceivable and it has been assumed that quicker 
TATs will concur with a more satisfied user. Our 
study seems to support this association between 
faster TAT and user satisfaction. 
TAT is a good quality indicator, since an improve-
ment in TAT implies an improvement in satisfac-
tion, evidenced by the reduction of the “indiffer-
ent” category. This is particularly clear because the 
improvements in HTAT were larger than in BTAT, as 
the %TATR shows in Table 1, and consequently the 
satisfaction with HTAT was also bigger, with less 
“indifferent”, more “satisfied” and less “dissatis-
fied” physicians. The highest reduction of %TAT 
noticed between haematological tests was proba-
bly due to the fact that their verification time was 
reduced most markedly. For haematological tests 
it is more frequent, in view of a pathological result, 
to recheck the sample quality than for biochemi-
cal tests. Samples yielding long clotting times or 
low platelet counts or low red blood cell counts 
are routinely checked for the presence of a clot by 
inserting applicator sticks into the whole blood 
sample. This is a time-consuming practice carried 
out frequently before the manual verification is 
done. Meanwhile, the BTAT also showed less “indif-
ferent” and more “satisfied” users, but the number 
of “dissatisfied” users had increased as well. We in-
terpret this as a non-intentional comparison: the 
satisfied users may be under the impression that 
BTAT has worsened, because they perceive a sub-
stantial raise in HTAT quality compared to BTAT.
The implementation of an expert system of au-
toverification based on RCV to speed up the deliv-
ery of results, even of those out of range of nor-
mality, has been a first step of a process of im-
provement of the emergency laboratory that has 
increased ED physician satisfaction. Further steps 
in this direction, as reporting patient results which 
surpass RCV, will be taken after the necessary tech-
nical modifications of our LIS.
In summary, we have introduced the autoverifica-
tion based on RCV in our laboratory as a simple 
and objective way to autoverify emergency test 
results. This significant innovation has led to bet-
ter TATs and higher physician satisfaction in the 
emergency room, a place where timeliness of test 
result reports is critical.
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